Cardiovascular disease is a leading cause of death in Ireland, with 9,000 deaths and 25,000 hospital admissions annually. OxygenCare partners with Defibtech to improve access to life-saving defibrillators in Ireland. Defibtech, a trusted American manufacturer, aims to provide reliable and affordable resuscitation devices globally. The partnership aims to ensure that defibrillators are available and functional when needed, as inadequate maintenance has rendered many devices non-operational. This collaboration between OxygenCare and Defibtech equips communities and organizations in Ireland with the tools and knowledge to respond effectively to cardiac emergencies, ultimately saving lives. Together, they are dedicated to safeguarding communities and saving lives.
Source link
OxygenCare announces new partnership to improve access to life-saving defibrillators in Ireland
